vincristine has been researched along with vincristine sulfate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Andreani, A; Burnelli, S; Calonghi, N; Cappadone, C; Granaiola, M; Leoni, A; Locatelli, A; Masotti, L; Morigi, R; Rambaldi, M; Shoemaker, RH; Stefanelli, C; Varoli, L; Voltattorni, M; Zini, M | 1 |
2 other study(ies) available for vincristine and vincristine sulfate
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Antitumor activity of new substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones and 3-(5-imidazo[2,1-b]thiadiazolylmethylene)-2-indolinones: selectivity against colon tumor cells and effect on cell cycle-related events.
Topics: Antineoplastic Agents; Apoptosis; Binding Sites; Cell Cycle; Cell Division; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; G2 Phase; HT29 Cells; Humans; Indoles; Molecular Structure; Ornithine Decarboxylase Inhibitors; Polyamines; Stereoisomerism; Structure-Activity Relationship; Thiadiazoles; Thiazoles; Tumor Cells, Cultured | 2008 |